Identification of the Serine Biosynthesis Pathway as a Critical Component of BRAF Inhibitor Resistance of Melanoma, Pancreatic, and Non–Small Cell Lung Cancer Cells
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-16-0798
Full Text
Open PDFAbstract
Available in full text
Date
May 12, 2017
Authors
Publisher
American Association for Cancer Research (AACR)